Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published May 10, 2020 | Published
Journal Article Open

Generation, Analyzing and in-vivo Drug Treatment of Drosophila Models with IBMPFD

Abstract

Missense mutations of p97/cdc48/Valosin-containing protein (VCP) cause inclusion body myopathy, Paget disease with frontotemporal dementia (IBMPFD) and other neurodegenerative diseases. The pathological mechanism of IBMPFD is not clear and there is no treatment. We generated Drosophila models of IBMPFD in adult flight muscle in vivo. Here we describe a variety of assays to characterize disease pathology and dissect disease mechanism, and the consequences of in vivo feeding of VCP inhibitors.

Additional Information

© 2020 Zhang et al. This article is distributed under the terms of the Creative Commons Attribution License (CC BY 4.0). We are grateful to the generous support from the National Institute of Health (National Institute on Aging), Glenn Foundation for Medical Research, the Natalie R. and Eugene S. Jones Fund in Aging and Neurodegenerative Disease Research, Kenneth Glenn Family Foundation, funds from the UCLA Laurie and Steven Gordon Commitment to Cure Parkinson's Disease, and Renee and Meyer Luskin Family Fund. We thank Rosaline Young, Mark Dodson, Hansong Deng, and Jina Yun for developing and optimizing the protocol (Clark et al., 2006; Deng et al., 2008; Yun et al., 2014). We have no competing interests.

Attached Files

Published - Bio-protocol3621.pdf

Files

Bio-protocol3621.pdf
Files (377.3 kB)
Name Size Download all
md5:f78660f0f8c8bfb7e3532564dae06d12
377.3 kB Preview Download

Additional details

Created:
August 19, 2023
Modified:
December 22, 2023